Since the foundation in 1997, the company has constantly advanced. Employees and management all share their belief in progress and innovation in stem cell therapy, which bears enormous medical potential. Vita 34 wants to participate actively in shaping this development.
Experienced chemists, biologists, biotechnologists, specialized physicians and professional medical/technical assistants have made Vita 34 into that what it is today – the German specialist for stem cells from umbilical cord blood and tissue. For almost 20 years we have not only been storing umbilical cord blood, rather we have set standards with our experience, research and innovations, far beyond the borders of Germany.
Market capitalization (27-Jun-2017)
Closing share price (27-Jun-2017)